Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial

Sellas' experimental blood cancer immunotherapy reduced the risk of death in clinical trial.

STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at statnews.com →

More in Health & Medicine

More from Tuesday 17 November →